Centre for Prions and Protein Folding Diseases, University of Alberta, 204 Brain and Aging Research Building, Edmonton, AB, T6G 2M8, Canada.
Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Cell Tissue Res. 2023 Apr;392(1):179-199. doi: 10.1007/s00441-022-03620-1. Epub 2022 Apr 23.
Tau is a microtubule-associated protein that plays crucial roles in physiology and pathophysiology. In the realm of dementia, tau protein misfolding is associated with a wide spectrum of clinicopathologically diverse neurodegenerative diseases, collectively known as tauopathies. As proposed by the tau strain hypothesis, the intrinsic heterogeneity of tauopathies may be explained by the existence of structurally distinct tau conformers, "strains". Tau strains can differ in their associated clinical features, neuropathological profiles, and biochemical signatures. Although prior research into infectious prion proteins offers valuable lessons for studying how a protein-only pathogen can encompass strain diversity, the underlying mechanism by which tau subtypes are generated remains poorly understood. Here we summarize recent advances in understanding different tau conformers through in vivo and in vitro experimental paradigms, and the implications of heterogeneity of pathological tau species for drug development.
tau 是一种微管相关蛋白,在生理和病理生理学中发挥着关键作用。在痴呆领域,tau 蛋白错误折叠与广泛的临床病理不同的神经退行性疾病有关,统称为 tau 病。根据 tau 株假说,tau 病的内在异质性可以用结构上不同的 tau 构象体“株”的存在来解释。tau 株在相关的临床特征、神经病理学特征和生化特征上可能存在差异。虽然先前对传染性朊病毒蛋白的研究为研究仅由蛋白质组成的病原体如何包含菌株多样性提供了有价值的经验教训,但 tau 亚型产生的潜在机制仍知之甚少。在这里,我们总结了通过体内和体外实验范例理解不同 tau 构象体的最新进展,以及病理 tau 物种异质性对药物开发的影响。